Source: International Congress 2014 – The assessment of comorbidities
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
F. Novelli, L. Vergura, M. Latorre, E. Bacci, M. L. Bartoli, S. Cianchetti, F. L. Dente, A. Di Franco, P. Paggiaro (Pisa, Italy). Obesity influences inflammatory phenotype mainly in early onset severe asthmatics. Eur Respir J 2014; 44: Suppl. 58, 974

Member's Comments

No comment yet.

Related content which might interest you: Implication of IL-18 in the chronic inflammation of severe refractory asthma Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Importance of concomitant local and systemic eosinophilia in uncontrolled asthma Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 Analysis of the inflammatory profile of children with controlled and uncontrolled severe asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Associated factors with persistent airflow limitation in asthma in U-BIOPRED Source: Annual Congress 2013 –Studies of asthma in man Year: 2013 Phenotypic characteristics of asthma with small airways involvement Source: International Congress 2016 – Notable abstracts on clinical problems related to asthma Year: 2016 Coagulation activity increases with disease severity in patients with asthma Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Induced sputum lipid mediators in severe asthma Source: International Congress 2016 – Translational studies in lung disease Year: 2016 Markers of eosinophilic airway inflammation in patients with severe and mild to moderate asthma Source: International Congress 2016 – Airway biomarkers Year: 2016 Small airways dysfunction is associated with poorer control in asthmatics with a preserved FEV1 Source: International Congress 2014 – Biomarkers of asthma control Year: 2014 The impact of input from a psychologist on a cohort of asthmatic frequent fliers Source: International Congress 2014 – Direct and indirect monitoring of comorbidities Year: 2014 Factors associated with irreversible airway obstruction in patients with asthma Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease? Year: 2014 U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Air trapping in relation to airways inflammation and bronchial responsiveness in patients with respiratory symptoms suggestive of asthma Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Discordance between asthma control parameters in patients with frequent vs infrequent asthma exacerbations Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Oxidative stress and systemic inflammation in different COPD phenotypes Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 The course and outcomes of pregnancy in women with bronchial asthma Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Asthma control is not related to large airways function Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014 Influence of psychological characteristics of patients for asthma control Source: International Congress 2014 – The assessment of comorbidities Year: 2014 The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms Source: International Congress 2014 – Biomarkers of asthma control Year: 2014